Robert Roswell Chai-Onn is CLO & EVP +1 at Valeant Pharmaceuticals International, Inc. (VRX). They have made 2 open-market trades across 1 company since 2010, most recently 2016-05-12.
CIK 0001502213
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $1.0M since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRX | 124,815 | $2.9M |
Shares reported on the most recent Form 4, priced at the 2016-05-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRX | SELL · 10b5-1 | 2015-05-04 | 2015-05-06 | $222.54 | $20.2M | -12.8% | +0.4% | +0.4% |
| VRX | SELL · 10b5-1 | 2015-03-02 | 2015-03-04 | $200.01 | $18.2M | -12.8% | +0.4% | +0.4% |
| VRX | SELL · 10b5-1 | 2014-06-23 | 2014-06-24 | $121.70 | $1.2M | -12.8% | +0.4% | +0.4% |
| VRX | SELL · 10b5-1 | 2014-05-13 | 2014-05-14 | $130.08 | $1.3M | -12.8% | +0.4% | +0.4% |
| VRX | SELL · 10b5-1 | 2014-03-17 | 2014-03-19 | $141.72 | $709K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2013-08-23 | 2013-08-23 | $99.30 | $500K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-05-27 | 2011-06-01 | $50.76 | $508K | -12.8% | +0.4% | +0.4% |
| VRX | SELL · 10b5-1 | 2010-11-09 | 2010-11-12 | $25.95 | $924K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.